Pardes Biosciences Inc (PRDS)
followers
·
Follow
Sector:
FINANCE
Industry:
GENERAL FINANCE
CEO:
Thomas G. Wiggans
Employees:
30
2173 SALK AVENUE, SUITE 250, PMB#052, CARLSBAD, CA, 92008
415-649-8758
-
Formally known as:
- FS Development Corp II
Are you looking for this stock instead?
Pardes Biosciences, Inc. focuses on discovering, developing, and commercializing novel therapeutics. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome coronavirus 2 infections and associated diseases.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|